Target intelligence / Profile preview

Multiple enzymes and cellular components

Molecular classification
Other
01

Overview

The term "Multiple enzymes and cellular components" is a non-specific designation used in pharmacological databases to classify agents that do not interact with a single, well-defined molecular target (DrugBank, 2024). Instead, these agents exert their therapeutic or toxic effects by interacting with a broad array of proteins, enzymes, nucleic acids, or lipid membranes within the cell (NCBI, 2023). This classification is frequently applied to cytotoxic chemotherapy agents like alkylating agents, which damage DNA and inhibit numerous enzymes involved in replication, or to antiseptic agents that disrupt cellular integrity globally (StatPearls, 2023). For example, ethanol and other alcohols act by fluidizing cell membranes and denaturing a wide variety of intracellular proteins rather than binding to a specific receptor (PubMed, 2022). Because of this lack of specificity, such agents often have a wide range of biological effects and a higher potential for systemic toxicity compared to targeted therapies. In a clinical context, this label serves as a placeholder when the primary effect is the result of a cumulative impact on the cellular environment rather than a discrete signaling pathway (NIH, 2024). Consequently, it is considered an imprecise target definition for modern drug discovery, which typically favors high-affinity interactions with specific molecular entities.

Other names
Multi-targetNon-specific cellular targetsVarious cellular componentsNon-specific interaction
02

Mechanism of action

Non-specific chemical modification of proteins and nucleic acids, or physical disruption of cellular membranes and organelles.

03

Biological functions

Other
04

Disease associations

CancerInfectionOther
05

Safety considerations

High off-target toxicitySystemic adverse effectsNarrow therapeutic indexCytotoxicity to healthy tissues
06

Interacting drugs

Cyclophosphamide

5 more in the full profile.

Beyond the preview

Go deeper on Multiple enzymes and cellular components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple enzymes and cellular components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call